Tekla Life Sciences Investors (HQL) Stock Forecast, Price & News

Tekla Life Sciences Investors' stock was trading at $14.21 on January 1st, 2023. Since then, HQL shares have decreased by 7.0% and is now trading at $13.22.
View the best growth stocks for 2023 here.

Tekla Life Sciences Investors saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 39,800 shares, a drop of 27.2% from the April 30th total of 54,700 shares. Based on an average trading volume of 75,500 shares, the short-interest ratio is presently 0.5 days.
View Tekla Life Sciences Investors' Short Interest.

Tekla Life Sciences Investors declared a quarterly dividend on Tuesday, May 16th. Investors of record on Thursday, May 25th will be given a dividend of $0.32 per share on Friday, June 30th. This represents a $1.28 dividend on an annualized basis and a yield of 9.68%. The ex-dividend date of this dividend is Wednesday, May 24th.
Read our dividend analysis for HQL.

ETFs with the largest weight of Tekla Life Sciences Investors (NYSE:HQL) stock in their portfolio include First Trust Income Opportunities ETF (FCEF),

Tekla Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.62 per share and currently has a dividend yield of 12.26%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for HQL.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY).

Tekla Life Sciences Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQL."

Tekla Life Sciences Investors' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Raymond James & Associates (1.23%), Wolverine Asset Management LLC (1.22%), Allspring Global Investments Holdings LLC (0.87%), LPL Financial LLC (0.67%), Ameriprise Financial Inc. (0.54%) and 180 Wealth Advisors LLC (0.44%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead and Kathleen Goetz.
View institutional ownership trends.

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HQL stock can currently be purchased for approximately $13.22.

Tekla Life Sciences Investors (NYSE:HQL) has a market capitalization of $332.35 million.

Tekla Life Sciences Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The official website for the company is www.teklacap.com. The company can be reached via phone at (617) 772-8500, via email at info@teklacap.com, or via fax at 617-772-8577.